Jade Biosciences, Inc. (JBIO) Form 10-K Annual Reports
Jade Biosciences, Inc. (JBIO) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: JBIO
CIK: 1798749
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerMark DeCost
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-30 | 2026-09-30 | 8-K | 0001193125-26-408287 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001231919-26-000932 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-096751 | View SEC Doc Filr Page |
| 10-Q | 2026-08-10 | 2026-06-30 | 10-Q | 0001193125-26-341242 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001193125-26-341229 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-17 | — | SCHEDULE 13G Filing | 0001104659-26-084623 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-08 | — | SCHEDULE 13G/A Filing | 0001274173-26-000169 | View SEC Doc Filr Page |
| 8-K | 2026-07-01 | 2026-06-29 | 8-K | 0001193125-26-292704 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-25 | 4 | 0001193125-26-286434 | View SEC Doc Filr Page |
| 3 | 2026-06-26 | 2026-06-25 | 3 | 0001193125-26-286421 | View SEC Doc Filr Page |
| 8-K | 2026-06-26 | 2026-06-25 | 8-K | 0001193125-26-283906 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 | 0001193125-26-267764 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 | 0001193125-26-267739 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 | 0001193125-26-267735 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 | 0001193125-26-267708 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 | 0001193125-26-267706 | View SEC Doc Filr Page |
| 8-K | 2026-06-11 | 2026-06-08 | 8-K | 0001193125-26-267640 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-09 | — | SCHEDULE 13D/A Filing | 0001104659-26-071942 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-05 | — | DEFA14A | 0001193125-26-259586 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2026-06-03 | 8-K | 0001193125-26-257733 | View SEC Doc Filr Page |
| 424B5 | 2026-06-04 | — | 424B5 | 0001193125-26-257722 | View SEC Doc Filr Page |
| 424B5 | 2026-06-03 | — | 424B5 | 0001193125-26-255444 | View SEC Doc Filr Page |
| 8-K | 2026-06-01 | 2026-06-01 | 8-K | 0001193125-26-249763 | View SEC Doc Filr Page |
| EFFECT | 2026-05-15 | — | EFFECT Filing | 9999999995-26-001672 | View SEC Doc Filr Page |
| EFFECT | 2026-05-15 | — | EFFECT Filing | 9999999995-26-001671 | View SEC Doc Filr Page |